julius clinical_figon brochure 2012

2
Julius Clinical ensures high-quality execution of global trials Our Global Reach JULIUS CLINICAL HAS COMPLETED MORE THAN 50 TRIALS TO DATE, WHERE OVER 130,000 PATIENTS HAVE BEEN ENROLLED ACROSS 30 COUNTRIES WORLDWIDE. Julius Clinical provides: Protocol Development Project Management Feasibility and Investigator network selection Contracting Training and Compliance Site Management and Monitoring Biostatistics and Data Management Pharmacovigilance Endpoint Adjudication Quality Assurance Clinical Study Report/Medical Writing Over 1000 clinical sites worldwide A Primary Care network with over 2000 GPs in the Netherlands Our track record includes collaborating with innovative pharmaceutical companies in a broad range of therapeutic areas. Our success is attributed to planning and performing late-phase clinical trials, with expertise covering both investigator-initiated and industry-sponsored trials. WITH ITS EXTENSIVE GLOBAL REACH AND REPUTATION, JULIUS CLINICAL IS ABLE TO CALL ON LARGE NUMBERS OF HIGHLY INFORMED AND MOTIVATED INVESTIGATORS WORLDWIDE TO TAKE PART IN CLINICAL TRIALS. NETWORKS ARE IN PLACE, AND NURTURED, TO ENSURE THAT THE REQUIRED EXPERTISE IS AVAILABLE EVEN AT SHORT NOTICE, WHATEVER THE THERAPEUTIC AREA. The Global Academic Consortium for Clinical Trials comprises of: Julius Clinical with coverage in Europe and Latin America and their main office located in Zeist, the Netherlands Cleveland Clinic Coordinating Center for Clinical Research (C5Research) with coverage in North America and their main office located at the Cleveland Clinic in Cleveland, Ohio, USA George Clinical with coverage in Australia, Asia, China and India and their main office located in Sydney, Australia. Broederplein 41–43 3703 CD Zeist The Netherlands t +31 (0)30 656 99 39 m +31 (0)621 16 29 69 e [email protected] w www.juliusclinical.com

Upload: cyrus-park

Post on 08-Jul-2015

124 views

Category:

Documents


1 download

DESCRIPTION

Julius Clinical attended FIGON Dutch Medicine Days (01-03 October 2012).

TRANSCRIPT

Page 1: Julius Clinical_FIGON Brochure 2012

Julius Clinical ensures high-quality execution of global trials

Our Global Reach

JULIUS CLINICAL HAS COMPLETED MORE THAN 50 TRIALS TO DATE, WHERE OVER 130,000 PATIENTS HAVE BEEN ENROLLED ACROSS 30 COUNTRIES WORLDWIDE.

Julius Clinical provides:

Protocol Development Project Management Feasibility and Investigator network selection Contracting Training and Compliance Site Management and Monitoring Biostatistics and Data Management Pharmacovigilance Endpoint Adjudication Quality Assurance Clinical Study Report/Medical Writing Over 1000 clinical sites worldwide A Primary Care network with over 2000 GPs

in the Netherlands

Our track record includes collaborating with innovative pharmaceutical companies in a broad range of therapeutic areas. Our success is attributed to planning and performing late-phase clinical trials, with expertise covering both investigator-initiated and industry-sponsored trials.

WITH ITS EXTENSIVE GLOBAL REACH AND REPUTATION, JULIUS CLINICAL IS ABLE TO CALL ON LARGE NUMBERS OF HIGHLY INFORMED AND MOTIVATED INVESTIGATORS WORLDWIDE TO TAKE PART IN CLINICAL TRIALS. NETWORKS ARE IN PLACE, AND NURTURED, TO ENSURE THAT THE REQUIRED EXPERTISE IS AVAILABLE EVEN AT SHORT NOTICE, WHATEVER THE THERAPEUTIC AREA.

The Global Academic Consortium for Clinical Trials comprises of:

Julius Clinical with coverage in Europe and Latin America and their main offi ce located in Zeist, the Netherlands

Cleveland Clinic Coordinating Center for Clinical Research (C5Research) with coverage in North America and their main offi ce located at the Cleveland Clinic in Cleveland, Ohio, USA

George Clinical with coverage in Australia, Asia, China and India and their main offi ce located in Sydney, Australia.

Broederplein 41–433703 CD ZeistThe Netherlands

t +31 (0)30 656 99 39m +31 (0)621 16 29 69e [email protected] www.juliusclinical.com

Page 2: Julius Clinical_FIGON Brochure 2012

Julius Clinical is a unique academic research organization (ARO) that combines strong scientifi c leadership and operational excellence to conduct innovative national and global clinical trials.

Julius Clinical is an affi liate of the University Medical Center Utrecht, the Netherlands.

Our partners include leading pharmaceutical, biotech, medical device, and food companies, as well as academic investigators. We focus on clinical trials that are likely to have a major impact on medicine and on people’s lives. Our fusion of scientifi c and operational expertise enables to deliver results effi ciently, on time and budget.

We are true partners with our clients, and share risks and responsibilities on all collaborative projects

We believe that applying scientifi c rigor to clinical research and operating as a professional business are essential to our success

Academic independence and the freedom to publish must be ours if we are to take on a leading role in a clinical trial

We continuously improve our methods and knowledge so that we can provide our partners with sensible, high-quality solutions

We are creative, non-conformist, and fl exible, and do not compromise on issues important to the success of a trial

We provide a great working environment, work hard, and have fun

We value our deep academic roots and independence as a company

A KEY STRENGTH OF JULIUS CLINICAL IS THE ACADEMIC EXPERTISE AND INTEGRITY OF ITS SCIENTIFIC TEAM.

Julius Clinical scientifi c staff:

have experience on study committees and work effectively with international networks of thought leaders.

can provide detailed input and advice at all stages of clinical trials, from design to implementation to interpretation.

uses its personal contacts with peers around the world to aid recruitment, and inspire and motivate investigators.

Overall, Julius Clinical’s in-house academic experience and close links with academics and clinicians at leading sites around the world, helps to achieve the desired results.

Julius Clinical VALUES

Julius Clinical offers academic leadership

We are an Academic Research Organization backed up by a CRO infrastructure